Found: 14
Select item for more details and to access through your institution.
Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 4, p. 621, doi. 10.1093/cid/ciab019
- By:
- Publication type:
- Article
Clinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus–Associated Nonalcoholic Fatty Liver Disease.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 12, p. 2087, doi. 10.1093/cid/ciaa382
- By:
- Publication type:
- Article
Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effect of Tesamorelin on Visceral Fat and Liver Fat in HIV-Infected Patients With Abdominal Fat Accumulation.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 4, p. 380, doi. 10.1001/jama.2014.8334
- By:
- Publication type:
- Article
Coronary Vasculature and Myocardial Structure in HIV: Physiologic Insights From the Renin-Angiotensin-Aldosterone System.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2021, v. 106, n. 2, p. e520, doi. 10.1210/clinem/dgaa792
- By:
- Publication type:
- Article
HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral Therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The effects of tesamorelin on phosphocreatine recovery in obese subjects with reduced GH.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89966-y
- By:
- Publication type:
- Article
Effects of Pitavastatin on Insulin Sensitivity and Liver Fat: A Randomized Clinical Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2018, v. 103, n. 11, p. 4176, doi. 10.1210/jc.2018-01446
- By:
- Publication type:
- Article
Effects of Pitavastatin on Insulin Sensitivity and Liver Fat: A Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle size.
- Published in:
- Clinical Endocrinology, 2012, v. 76, n. 2, p. 220, doi. 10.1111/j.1365-2265.2011.04195.x
- By:
- Publication type:
- Article